))
The ASCO Daily News Podcast features oncologists discussing the latest research and therapies in their areas of expertise.
…
continue reading
Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care professionals. Learn more about our award-winning journal!
…
continue reading
Peer-Spectives is a podcast series that is moderated by Robert Figlin, MD, and features various oncology thought-leaders covering the latest clinical developments in a wide range of tumor types.
…
continue reading
With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
…
continue reading
The Oncology Podcast including Supportive Care Matters by Dr. Bogda Koczwara, are brought to you by The Oncology Network. The Oncology Network are producers of digital resources that support busy oncology health professionals. For more information visit our website www.oncologynews.com.au. We also invite Healthcare Professionals to subscribe to The Oncology Newsletter and our Oncology Portal for free and exclusive resources at: www.oncologynetwork.com.au
…
continue reading
The Video Journal of Oncology (VJOncology) podcast covers the latest solid oncology news from international experts, including breast, lung, skin, genitourinary, head and neck, gynecological and more. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjoncology.com
…
continue reading
Oncology News and Views from Photon Media. For more info, please visit photonmedia.org.
…
continue reading
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us ...
…
continue reading
Oncology On The Go is a weekly podcast that talks to authors and experts to thoroughly examine featured articles in the journal ONCOLOGY and review other challenging treatment scenarios in the cancer field from a multidisciplinary perspective. Our discussions also offer timely insight into topics ranging from recent FDA approvals to relevant research presented at major oncology conferences. As the home of the journal ONCOLOGY, CancerNetwork offers different perspectives on oncology/hematolog ...
…
continue reading
Join the American Lung Association and HCPLive every month as Dr. Al Rizzo interviews world-leading experts on the great challenges, accomplishments, and stories in respiratory medicine. Get the latest lung health news, including future Lungcast topics and guests, by signing up for our newsletter at Lung.org. (https://www.lung.org)
…
continue reading
A urology podcast, focussing on all things prostate, kidney, bladder, testis and penile cancer. Join Professor Declan Murphy and Dr Renu Eapen from Peter MacCallum Cancer Centre in Melbourne for this regular dive into the world of genitourinary (GU) Oncology and Urology. Regular guests from all over the world, from every walk of life. Find out more gucast.org
…
continue reading
Anesthesiology News will be publishing a new season of our popular podcast series, “On the Case” and “Ask the Experts.” “On the Case” is a review series that features the authors of our popular case report series. We hear the behind-the-scenes story on the most unique clinical case studies published in the magazine directly from the professionals who managed them. The first episode of this new season features an interview with L. Jane Stewart, MD, JD, MPH, who co-wrote a case report about a ...
…
continue reading
As the leading authoritative, peer-reviewed audio source of oncology clinical news for clinicians and healthcare professionals, the AJO Podcast regularly brings you exclusive interviews with the world's leading researchers and clinicians responsible for pushing out the boundaries of science and practice. Medicine, screening, radiotherapy, surgery, clinical trials, cancer care, epidemiology and prevention are covered impartially to give busy cancer professionals access to conversational spoke ...
…
continue reading
The Oppenheimer Let’s Talk Future Podcast explores a variety of market perspectives, bringing our firm’s financial thought leaders directly to you.
…
continue reading
Interviews with experts on the top news and controversies in the field of oncology today.
…
continue reading
The latest clinical medicine and health policy news for healthcare professionals, delivered each weekday by host Nick Andrews and MDedge editors. The information in this podcast is provided for informational and educational purposes only.
…
continue reading
In collaboration with Audio Journal of Oncology, OT now features audio-reports and interviews about new clinical research from major cancer meetings and key journals. The programs are created by the leading medical audioservice worldwide, Audio Medica, whose Audio Journal of Oncology has been bringing these lively listen-in shows to members of the cancer care team in various audio formats since 1992. Scientific Editors are: George Canellos, MD, of Dana-Farber Cancer Institute; J. Gordon McVi ...
…
continue reading
The Greek meaning of evangelist is "bringing the good news" In this podcast, patient advocate and lung cancer survivor Dave Bjork brings the good news by serving up stories about the good people in life sciences who are doing amazing work in lung cancer research and care. He calls them “brilliant but not famous." But they are all well known and respected in their field among their peers. From academic researchers to lung cancer clinicians, hear about their work but also their personal storie ...
…
continue reading
Audio-reports and interviews done in collaboration with Audio Medica and its founding Editor Peter Goodwin. Audio Medica's Audio Journal of Oncology has been bringing lively listen-in shows to members of the cancer care team in various audio formats since 1992. Scientific Editors are George Canellos, MD, of Dana-Farber Cancer Institute; J. Gordon McVie, MD, of the European Institute of Oncology and Chair of the Editorial Board of OT's UK Edition; Pat Price, MD, of Christie Hospital, also on ...
…
continue reading
The Lancet News is a weekly podcast brought to you by The Lancet. Our editors, Tim Dehnel and Dara Mohammadi, report on important, interesting, and sometimes quirky health-related happenings from around the world, while providing a rundown of the latest news from The Lancet, The Lancet Infectious Diseases, The Lancet Neurology, and The Lancet Oncology.
…
continue reading
The ASCO in Action Podcast provides analysis and commentary on cancer policy and practice issues. The podcast is hosted by Dr. Clifford Hudis, CEO of the American Society of Clinical Oncology. ASCO in Action, the society’s internal wire-service, provides the latest news and analysis related to cancer policy. These updates provide snapshots of ASCO’s ongoing advocacy efforts, as well as opportunities for ASCO members and guests to take action on critical issues affecting the cancer community. ...
…
continue reading
Welcome to the Precision Medicine Podcast by Trapelo. This is the podcast where experts come to discuss the problems oncologists, reference labs, and payers face as precision medicine grows, and consider solutions for advancing the quality of patient-centered cancer care.
…
continue reading
Misconceptions surrounding health and medicine are common. Get the straight science – from The Science of Health Podcast, featuring medical experts and expertise from University Hospitals.
…
continue reading
Podcasts360, powered by Consultant360, features short interviews with medical professionals about current research, news, and general information for health care providers in 35+ specialties.
…
continue reading
Cancer.Net Podcast features trusted, timely, and compassionate information for people with cancer, survivors, their families, and loved ones. Expert tips on coping with cancer, recaps of the latest research advances, and thoughtful discussions on cancer care
…
continue reading
The Onco'Zine Brief is an interview and discussion program presented by Peter Hofland and covers a broad range of topics and timely news updates with information from all oncology disciplines and sub-specialties from around the world. The Onco'Zine Brief is a sponsor-supported, program for healthcare professionals involved in the management and care of cancer patients as well as cancer patients and their family and friends. If you like to join us as a sponsor or advertisers, download our med ...
…
continue reading
Welcome to CEConversations, a clinical podcast presented by Creative Educational Concepts designed to improve clinician performance and optimize patient outcomes.
…
continue reading
The "WORD of HOPE" Ovarian Cancer Podcast is produced in partnership with WORD (Women's Oncology Research & Dialogue) and Libby's H*O*P*E*. Co-hosted by Nate Manahan (Executive Direct at WORD) and Paul Cacciatorre (Co-Founder of Libby's H*O*P*E*), the "WORD of HOPE"� Ovarian Cancer Podcast strives to provide news and commentary on ovarian cancer research, treatment and more. The intent of this podcast is to better prepare an ovarian cancer survivor or caregiver for discussions with their doc ...
…
continue reading
Are you working in healthcare market research or competitive intelligence or market intelligence? Do you often face information overload, from the pharma news portals, clinical trial registries, regulatory agencies, financial reports, investor releases, pharma summits, investment news, and financial summits etc.? It is hard to keep a track of all the forces (external and internal) that affects a product’s development and performance in the healthcare/ pharmaceutical market. We at RAS Life Sc ...
…
continue reading
Cancer Docs Talk is produced by Sylvester Comprehensive Cancer Center at University of Miami Miller School of Medicine. This podcast is hosted by renowned lung cancer oncologist Gilberto Lopes, M.D., who is associate director of Global Oncology at Sylvester. Guests include top oncologists and researchers who will be talking about the latest cancer news, research findings and new therapies in progress.
…
continue reading
1
Oncologists Overtreat Patients at End of Life
10:45
10:45
Play later
Play later
Lists
Like
Liked
10:45
When it comes to end-of-life care for patients with cancer, “I think that there is a real deficit in our training,” says Nathan I. Cherny, MD, director of the Cancer Pain and Palliative Medicine Service at Shaare Zedek Medical Center in Jerusalem, Israel. Dr. Cherney and colleagues recently examined factors contributing to oncologists overtreating …
…
continue reading
1
Nothing to fear? Facing the challenge of fear of cancer recurrence
49:34
49:34
Play later
Play later
Lists
Like
Liked
49:34
Send us a text Confronting the Fear of Cancer Recurrence Welcome to the latest Series of Supportive Care Matters, a podcast hosted by Medical Oncologist and International Cancer Survivorship Expert, Professor Bogda Koczwara AM. The fear of cancer returning is a silent struggle for many survivors, often overshadowing their recovery. In Episode 1 of …
…
continue reading
1
S1 Ep149: Highlighting Insights From the Marginal Zone Lymphoma Workshop
12:30
12:30
Play later
Play later
Lists
Like
Liked
12:30
Following the 2024 Marginal Zone Lymphoma (MZL) Workshop, CancerNetwork® spoke with multiple attending clinicians about insights they shared regarding the disease state, covering the significance of the workshop and its contribution to advancing research in areas such as prognostic factors and managing adverse events (AEs) related to the disease. T…
…
continue reading
1
Post-ASH non-malignant highlights: updates in sickle cell disease, thalassemia, and hemophilia
18:27
18:27
Play later
Play later
Lists
Like
Liked
18:27
This episode of the VJHemOnc podcast covers updates in non-malignant hematological diseases from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, which took place in San Diego, CA. You will hear the latest updates in sickle cell disease (SCD), thalassemia, and hemophilia from leading experts. First, Sophia Delicou, MD, H…
…
continue reading
Welcome to this week’s podcast by VJOncology, where we delve into the emerging trends and challenges in the field of cellular therapies for oncology. Our expert panel includes Leonardo Ferreira (The Medical University of South Carolina, Charleston, SC), who discusses the groundbreaking potential and current obstacles of CAR T cells in treating soli…
…
continue reading
1
ENZA-P Big news Update: LuPSMA and enza improves overall survival
29:36
29:36
Play later
Play later
Lists
Like
Liked
29:36
A breaking news podcast from ASCO GU in San Francisco! Prof Louise Emmett (St Vincent's, Sydney), has just read out the latest update from the ENZA-P trial (and simultaneous publication in Lancet Oncology), reporting that the combination of LuPSMA and enzalutamide improves overall survival when compared with enzalutamide alone, in men with poor pro…
…
continue reading
1
“Look, This Treatment Works”: Bobby and Mudit on LDRT and Benign Indications
46:36
46:36
Play later
Play later
Lists
Like
Liked
46:36
Accelerators co-host Dr. Matt Spraker is joined by radiation oncologists Drs. Bobby Koneru and Mudit Chowdhary for an update on low dose radiotherapy for osteoarthritis! Dr. Koneru is a radiation oncologist in Freeport, IL and prolific social media educator on benign indications. Dr. Chowdhary is a radiation oncologist at Northside Hospital in Atla…
…
continue reading
Check out this week's QuadCast as we highlight the role of staging brain MRI in metastatic breast cancer, the link between acute and late toxicity in prostate cancer treatment, the benefits of liver SBRT over TACE, and more. Check out the website and subscribe to the newsletter! www.quadshotnews.com Founders & Lead Authors: Laura Dover & Caleb Dula…
…
continue reading
1
S1 Ep148: Navigating Management and Dosing Considerations for Amivantamab in NSCLC
26:34
26:34
Play later
Play later
Lists
Like
Liked
26:34
In the first edition of a special 3-part podcast series, CancerNetwork® spoke with Daniel Morgensztern, MD; Mary Ellen Flanagan, NP; and Janelle Mann, PharmD, BCOP, about best practices for implementing recently approved bispecific antibodies into cancer care. Their initial discussion focused on the clinical trial results, administration protocols,…
…
continue reading
1
Post-ASH myeloma highlights: key takeaways for community physicians & trials to look out for in 2025
18:29
18:29
Play later
Play later
Lists
Like
Liked
18:29
This podcast brings you exclusive updates on multiple myeloma from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, held in San Diego, CA. In this episode, experts Karthik Ramasamy, MBBS, MRCP, FRCPath, PhD, Oxford University Hospitals NHS Foundation Trust, Oxford, UK, Rahul Banerjee, MD, FACP, Fred Hutchinson Cancer Cen…
…
continue reading
1
Therapeutic Advances Across GI Cancers: Highlights From GI25
21:13
21:13
Play later
Play later
Lists
Like
Liked
21:13
Dr. Shaalan Beg and Dr. David Wang discuss key abstracts in GI cancers from the 2025 ASCO Gastrointestinal Cancers Symposium, including major advances in CRC, neoadjuvant approaches in esophageal cancer, and innovative studies on ctDNA. TRANSCRIPT Dr. Shaalan Beg: Hello and welcome to the ASCO Daily News Podcast. I'm Dr. Shaalan Beg. I'm a medical …
…
continue reading
Check out this week's QuadCast as we highlight bone SBRT guidelines, best practice in the treatment of WHO grade II meningioma, frequency of partial breast IMRT treatment, and more. Check out the website and subscribe to the newsletter! www.quadshotnews.com Founders & Lead Authors: Laura Dover & Caleb Dulaney Podcast Host: Sam Marcrom…
…
continue reading
1
S1 Ep147: Expanding and Advancing the Future of Renal Cell Carcinoma Treatment
18:04
18:04
Play later
Play later
Lists
Like
Liked
18:04
In collaboration with KidneyCAN, CancerNetwork® spoke with Eric Jonasch, MD, a professor in the Department of Genitourinary Medical Oncology of the Division of Cancer Medicine, and the director of the von Hippel Lindau Center at the University of Texas MD Anderson Cancer Center in Houston, Texas, about the missions and goals of the Kidney Cancer Re…
…
continue reading
1
Future-gazing radioligand therapy in prostate cancer | With Oliver Sartor and Michael Hofman
37:27
37:27
Play later
Play later
Lists
Like
Liked
37:27
Look who popped into the GU Cast studio this week for a chat about where we are going next with radioligand therapy (RLT) for prostate cancer! Professors Oliver Sartor (Mayo Clinic, Rochester) and Michael Hofman (Peter Mac, Melbourne), are two of the world's most pre-eminent experts in the world of RLT for prostate cancer. They were each respective…
…
continue reading
1
Post-ASH AML highlights: novel approaches to frontline therapy, advances with menin inhibitors, & managing FLT3-ITD+ AML
28:59
28:59
Play later
Play later
Lists
Like
Liked
28:59
In this podcast, we bring you exclusive updates on acute myeloid leukemia (AML) from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, which took place in San Diego, CA. You will hear insights into novel approaches to frontline chemotherapy and BCL2 inhibition from experts Ioannis Mantzaris, MD, Montefiore Medical Center/…
…
continue reading
1
Advances in Adjuvant Therapy for High-Risk Early Breast Cancer With Germline Mutations
19:38
19:38
Play later
Play later
Lists
Like
Liked
19:38
Dr. Jasmine Sukumar and Dr. Dionisia Quiroga discuss advances in adjuvant therapy for patients with early breast cancer and BRCA1/2 mutations, including how to identify patients who should receive genetic testing and the significant survival benefits of olaparib that emerged from the OlympiA trial. TRANSCRIPT Dr. Jasmine Sukumar: Hello, I'm Dr. Jas…
…
continue reading
In this episode of Let's Talk Future™, Jane Ross is joined by Colin Rusch to explore the fascinating world of physical AI. They delve into how generative AI is transforming industries by merging with physical machines. From warehouse automation to mining operations, they discuss groundbreaking applications, key players like Tesla and Symbotic, and …
…
continue reading
1
The L.A. Wildfires Bring Massive Health Concern
8:10
8:10
Play later
Play later
Lists
Like
Liked
8:10
The Los Angeles wildfires have destroyed thousands of homes and stores, and left entire communities in ash and rubble. And while lives have already been lost, experts are now discussing the long-term health impact for those who lived or worked in the area. "The general practitioners, the anesthesiologists, the entire medical community needs to be e…
…
continue reading
1
Post-ASH MPN highlights: key trial updates in MF, novel approaches being explored in R/R disease, & more!
22:21
22:21
Play later
Play later
Lists
Like
Liked
22:21
This podcast episode covers key highlights in myeloproliferative neoplasms (MPNs) from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, which took place in San Diego, CA. First, you will hear key trial updates in myelofibrosis (MF) from Andrew Kuykendall, MD, Moffitt Cancer Center, Tampa, FL, Lucia Masarova, MD, The Univ…
…
continue reading
Check out this week's QuadCast as we highlight the results of RTOG 0920 for adjuvant therapy in H&N cancer, the benefit of bone protective agents in patients receiving radium 223 + enzalutamide, the benefit of incorporating counseling into smoking cessation strategies, and more. Check out the website and subscribe to the newsletter! www.quadshotnew…
…
continue reading
1
Race-Neutral Approach to Pulmonary Function Testing with Meredith McCormack, MD, and Loretta Que, MD
20:53
20:53
Play later
Play later
Lists
Like
Liked
20:53
In this episode, Dr. Meredith McCormack of Johns Hopkins University and Dr. Loretta Que of Duke University to discuss “race-based normal values” in medicine, particularly in regard to pulmonary function tests (PFT). The controversial practice of using a patient’s self-reported race to adjust a standard “normal” range has been shown to lead to poten…
…
continue reading
1
S1 Ep146: Conducting Early Phase Trials of Promising Treatments in Neuro-Oncology
11:05
11:05
Play later
Play later
Lists
Like
Liked
11:05
In a conversation with CancerNetwork®, Shewetal Mehta, PhD, spoke about her research team’s focuses in moving novel brain cancer therapies down the pipeline as part of an early phase clinical trials program at the Ivy Brain Tumor Center. Mehta, the deputy director and pre-clinical core leader at the Ivy Brain Tumor Center of Barrow Neurological Ins…
…
continue reading
1
KEYNOTE-006 Study 10-Year Survival Data Confirm PD-L1 Checkpoint Inhibition Best for Patients With Advanced Melanoma
7:33
7:33
Play later
Play later
Lists
Like
Liked
7:33
The pivotal role of programmed death-ligand 1 (PD-L1) checkpoint inhibition for treating advanced melanoma has been confirmed in findings from the KEYNOTE-006 study comparing the anti-PD-L1 antibody pembrolizumab immunotherapy with the anti-cytotoxic T-lymphocyte associated protein 4 (CTLA-4) drug ipilimumab for treating patients with unresectable …
…
continue reading
1
Therapeutic options for PD1 refractory skin cancer
32:07
32:07
Play later
Play later
Lists
Like
Liked
32:07
In this podcast, we explore the latest advancements in the treatment of PD-1 refractory melanoma. This week, we are joined by Allison Betof Warner (Stanford Cancer Center, Stanford, CA) and Omid Hamid (The Angeles Clinic and Research Institute, Los Angeles, CA) and Inderjit Mehmi (The Angeles Clinic and Research Institute, Los Angeles, CA). We will…
…
continue reading
1
Post-ASH NHL highlights: novel combinations in the frontline setting and advancements with immunotherapy in the R/R setting
31:20
31:20
Play later
Play later
Lists
Like
Liked
31:20
Today's podcast showcases key updates in non-Hodgkin lymphoma (NHL) from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, which took place in San Diego, CA. First, you will hear from Gilles Salles, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, Catherine Diefenbach, MD, NYU Langone, New York, NY, and Jia …
…
continue reading
1
Meet Dr. Eric Singhi the Assistant Professor of both the Department General Oncology Division of Cancer Medicine and the Department of Thoracic Head and Neck Medical Oncology at the University of Texas ...
39:41
39:41
Play later
Play later
Lists
Like
Liked
39:41
On today’s episode, meet Dr. Eric Singhi. Dr. Singhi is the Assistant Professor of both the Department General Oncology Division of Cancer Medicine and the Department of Thoracic Head and Neck Medical Oncology at the University of Texas MD Anderson Cancer Center in Houston. He received his medical degree at the Medical University of South Carolina.…
…
continue reading
1
S1 Ep145: Psilocybin May Help Address Cancer-Related Psychological Concerns
16:29
16:29
Play later
Play later
Lists
Like
Liked
16:29
CancerNetwork® spoke with Michael P. Bogenschutz, MD, director of the NYU Langone Center for Psychedelic Medicine and professor of Psychiatry at NYU Grossman School of Medicine, about psilocybin-assisted psychotherapy (PAP) in managing psychological challenges associated with serious cancer diagnoses following the publication of a pooled analysis o…
…
continue reading
1
“I Care About You as a Fellow Human”: In Conversation With Dr. Stacy Wentworth
58:30
58:30
Play later
Play later
Lists
Like
Liked
58:30
The Accelerators (Drs. Matt Spraker and Simul Parikh) host Dr. Stacy Wentworth, Radiation Oncologist, Author, and Podcaster! We discuss her career and how she developed her voice as a physician content creator. Do not miss her Less Radical narrative podcast about the life of Bernie Fisher, it is a masterpiece! In this episode, we cover our experien…
…
continue reading
1
Post-ASH MDS highlights: managing anemia in LR-MDS and novel approaches to treating HR-MDS
19:02
19:02
Play later
Play later
Lists
Like
Liked
19:02
This podcast is the second episode in our series spotlighting key highlights from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, which took place in San Diego, CA. This episode focuses on updates in myelodysplastic syndromes (MDS). You will hear insights into managing anemia in lower-risk MDS (LR-MDS) from Sophie Park,…
…
continue reading
1
Evaluating the Clinical Applications of ctDNA in Colorectal Cancer
12:30
12:30
Play later
Play later
Lists
Like
Liked
12:30
In this week’s podcast, we will provide updates the emerging roles of circulating tumor DNA (ctDNA) in managing colorectal cancer. We are joined by Michael Brian LaPelusa, MD, University of Texas MD Anderson Cancer Center, Houston, TX; Juan Manuel O’Connor, MD, MSc, Instituto Alexander Fleming, Buenos Aires, Argentina; Anup Kasi, MD, MPH, Universit…
…
continue reading
1
AUDIO JOURNAL OF ONCOLOGY: Randomized Study Found Surgery-Sparing Active Monitoring Safe in Patients With Low-risk DCIS
13:47
13:47
Play later
Play later
Lists
Like
Liked
13:47
SAN ANTONIO, USA—In patients with hormone receptor-positive, HER2-negative, low-risk ductal carcinoma in situ (DCIS) active monitoring, compared with surgery, resulted in no difference in terms of cancer outcomes in the multicenter, randomized COMET study that compared oncologic outcomes of patients randomized to guideline-concordant care (with sur…
…
continue reading
Dr Toni Choueiri, Chief of GU Oncology at Dana-Farber Cancer Institute (Boston, USA) returns to GU Cast with members of his team at Dana Farber Cancer Institute to discuss our favourite lists of top GU Oncology papers for 2024. Toni has posted these now legendary lists at the end of each year on Twitter/X since the start of Covid, and they have bec…
…
continue reading
1
Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified
16:09
16:09
Play later
Play later
Lists
Like
Liked
16:09
Although one in five colorectal cancers having microsatellite instability and expressing the Werner Helicase (WRN) gene could be treated with drugs that inhibit WRN, the effectiveness of such an approach has been limited by resistance. However, researchers identified the Cys727 mutation as being solely responsible for WRN inhibitor resistance. This…
…
continue reading
Check out this week's QuadCast as we highlight spinal cord constraints for spine SBRT, published results of RTOG 1112 where liver SBRT shines, the role of prophylactic nodal RT in prostate SBRT, and more. Check out the website and subscribe to the newsletter! www.quadshotnews.com Founders & Lead Authors: Laura Dover & Caleb Dulaney Podcast Host: Sa…
…
continue reading
1
S1 Ep144: SABCS 2024 Data Show ‘Great Steps Forward’ in Breast Cancer Care
41:02
41:02
Play later
Play later
Lists
Like
Liked
41:02
Following the 2024 San Antonio Breast Cancer Symposium (SABCS), Paolo Tarantino, MD, and Matteo Lambertini, MD, PhD, co-hosted a live X Space with CancerNetwork® and spoke about updated trial findings that may impact the breast cancer treatment paradigm. Tarantino is a clinical research fellow at Dana-Farber Cancer Institute and Harvard Medical Sch…
…
continue reading
1
AUDIO JOURNAL OF ONCOLOGY: Safe to Spare Post-Mastectomy Chest Wall Radiotherapy in Most Patients with Intermediate Risk Breast Cancer
15:27
15:27
Play later
Play later
Lists
Like
Liked
15:27
SAN ANTONIO, USA—There was no benefit from chest wall irradiation in patients who had intermediate-risk breast cancer, according to findings reported at the 2024 San Antonio Breast Cancer Symposium from the BIG 2-04 MRC SUPREMO international phase three randomized controlled trial. At the conference Ian Kunkler MA, MB, BChir, Professor at Edinburgh…
…
continue reading
1
Tumor-Agnostic Classifier & Screener Aids Targeted Drug Development
9:21
9:21
Play later
Play later
Lists
Like
Liked
9:21
A tumor-agnostic classifier and screening tool was announced at ESMO Congress 2024 in Barcelona. It was created to make it easier and quicker to develop new drugs that have specific molecular targets, and thus have potential anti-cancer efficacy irrespective of tumor type or location. The ESMO Tumour-Agnostic Classifier and Screener was the result …
…
continue reading
1
Early Switch to Immunotherapy Recommended After BRAFV600 Mutation Targeted Therapy for Advanced Melanoma
7:25
7:25
Play later
Play later
Lists
Like
Liked
7:25
Findings from a study of patients receiving targeted therapy for their BRAFV600 mutation-positive advanced melanoma, suggest that switching early to immune checkpoint inhibition appeared to bring better rates of overall survival than saving immunotherapy for use as salvage treatment later on. The ESMO 2024 Annual Congress heard from the randomized …
…
continue reading
1
Biotech in 2025: Opportunities Amid Uncertainty
18:58
18:58
Play later
Play later
Lists
Like
Liked
18:58
In this episode of Let's Talk Future™, Jane Ross and Michael Margolis, R.Ph., Head of Healthcare Investment Banking at Oppenheimer, discuss the biotech sector's 2025 outlook. Topics include interest rates, healthcare policy changes, M&A, and IPO trends. Despite challenges, Michael highlights strong innovation and upcoming catalysts as opportunities…
…
continue reading
1
This Year in Pulmonology: The 2024 Lungcast Recap
18:58
18:58
Play later
Play later
Lists
Like
Liked
18:58
Ever since the show first launched, Lungcast has provided pulmonologists and health care providers in general a chance to take part in ongoing conversations regarding lung health between experts, patients, and patient advocates. In this recap episode, the Lungcast team reflects on these conversations by highlighting some of the many interviews feat…
…
continue reading
In this week’s podcast, we will discuss the most recent developments in breast cancer from the 2024 San Antonio Breast Cancer Symposium (SABCS) congress in San Antonio, TX. Join us as renowned experts exclusively speak with us on anticipated findings from clinical trials across different breast cancer subtypes. Gaia Griguolo from University of Pado…
…
continue reading
1
Novel immune checkpoint targets beyond PD-1 and CTLA-4 in solid tumors
13:59
13:59
Play later
Play later
Lists
Like
Liked
13:59
This week’s podcast from VJOncology brings you the latest updates on novel checkpoint inhibitors that target LAG-3, TIGIT, and TIM3 in solid tumors. Our panel of experts share the latest findings from their clinical trials that tested the efficacy of different immune checkpoint inhibitors in neoplastic tumors. Myriam Chalabi from the Netherlands Ca…
…
continue reading
1
Post-ASH CLL highlights: BTK inhibitors & degraders, bispecific antibodies, & more!
16:31
16:31
Play later
Play later
Lists
Like
Liked
16:31
VJHemOnc recently attended the 66th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, CA, where we gained expert insights into cutting-edge research in hematological malignancies. This podcast series will cover highlights in a variety of disease areas. Today's episode focuses on chronic lymphocytic leukemia (CLL). You…
…
continue reading
1
Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified
7:33
7:33
Play later
Play later
Lists
Like
Liked
7:33
The pivotal role of programmed death-ligand 1 (PD-L1) checkpoint inhibition for treating advanced melanoma has been confirmed in findings from the KEYNOTE-006 study comparing the anti-PD-L1 antibody pembrolizumab immunotherapy with the anti-cytotoxic T-lymphocyte associated protein 4 (CTLA-4) drug ipilimumab for treating patients with unresectable …
…
continue reading
1
Clear Benefit From Early Checkpoint Inhibition in Locally Advanced, High-Risk Cervical Cancer
6:59
6:59
Play later
Play later
Lists
Like
Liked
6:59
A clinically meaningful benefit in overall survival was found in the second interim analysis of the randomized, double-blind, Phase III KEYNOTE-A18 study of immunotherapy together with concurrent chemoradiotherapy among 1,060 patients who had newly diagnosed, previously untreated high-risk locally advanced cervical cancer. A multinational team of r…
…
continue reading
1
How to Recognize and Respond to Toxic Behavior
35:06
35:06
Play later
Play later
Lists
Like
Liked
35:06
We’ve all dealt with toxic people but what do you do when someone’s actions begin to affect your emotional well-being? Sometimes, the answer lies not in changing the person who hurts us – but in changing how we react to them. Psychiatrist Dr. Patrick Runnels, Chief Medical Officer of Population Health at University Hospitals Cleveland, explains how…
…
continue reading
1
How to Advance Cancer Care for Native Americans
18:23
18:23
Play later
Play later
Lists
Like
Liked
18:23
Native American oncologist Dr. Amanda Bruegl and Dr. Noelle LoConte discuss culturally tailored interventions and the importance of community engagement to advance cancer prevention, diagnosis, and treatment for Native communities. TRANSCRIPT ASCO Daily News: Hello and welcome to the ASCO Daily News Podcast. I'm Geraldine Carroll, a reporter for th…
…
continue reading
Part 2 of our GU Cast Conference Highlights from Shanghai including discussions with Dr Stephen Freedland (Los Angeles), Dr Liang Liang (Shaanxi), Dr Andrea Necchi (Milano), Dr Xiaojie Bian (Shanghai), and Dr Hongkai Wang (Shanghai). Declan Murphy travelled to Shanghai for the 14th GU Oncology Academic Meeting hosted by Fudan University Shanghai Ca…
…
continue reading
1
AUDIO JOURNAL OF ONCOLOGY: Increased Dietary Fiber Brings Longer Survival and Less GVHD After Allogeneic Stem Cell Transplantation
12:28
12:28
Play later
Play later
Lists
Like
Liked
12:28
SAN DIEGO, USA—A higher intake of dietary fiber after allogeneic hematopoietic cell transplantation was associated with increased overall survival, a lower incidence of graft-versus-host disease, an increase in fecal concentrations of beneficial short-chain fatty acids and greater microbial diversity of the gut microbiome. These findings came from …
…
continue reading
Check out this week's QuadCast as we highlight ideal adjuvant management of endometrial cancer from GOG 258, the best approach to locally recurrent rectal cancer, and also highlight recurrent GBM management guidelines. Welcome to 2025! Check out the website and subscribe to the newsletter! www.quadshotnews.com Founders & Lead Authors: Laura Dover &…
…
continue reading
